Basic Information
Enhertu
65597-406
Regulatory Information
65597-406
BLA761139
C73585
February 22, 2024
USA
These highlights do not include all the information needed to use ENHERTU safely and effectively. See full prescribing information for ENHERTU. ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use Initial U.S. Approval: 2019
HUMAN PRESCRIPTION DRUG LABEL
17
Company Information
068605067
Active Ingredients
HISTIDINE
Code: 4QD397987E
Class Code: IACT
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
Code: X573657P6P
Class Code: IACT
POLYSORBATE 80
Code: 6OZP39ZG8H
Class Code: IACT
SUCROSE
Code: C151H8M554
Class Code: IACT
Active Moieties
TRASTUZUMAB DERUXTECAN
Code: 5384HK7574